E. Gehan

1.4k total citations · 1 hit paper
17 papers, 1.1k citations indexed

About

E. Gehan is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, E. Gehan has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in E. Gehan's work include Sarcoma Diagnosis and Treatment (11 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cardiac tumors and thrombi (3 papers). E. Gehan is often cited by papers focused on Sarcoma Diagnosis and Treatment (11 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cardiac tumors and thrombi (3 papers). E. Gehan collaborates with scholars based in United States, Canada and Switzerland. E. Gehan's co-authors include Teresa J. Vietti, Melvin Tefft, Ayten Cangır, E. Omer Burgert, John M. Kissane, Roger G. Evans, Fred Askin, P. Thomas, M. Nesbit and Mariella C. Tefft and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer.

In The Last Decade

E. Gehan

17 papers receiving 1.0k citations

Hit Papers

Multimodal therapy for the management of primary, nonmeta... 1990 2026 2002 2014 1990 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Gehan United States 13 869 353 298 281 270 17 1.1k
William Cham United States 12 436 0.5× 241 0.7× 128 0.4× 94 0.3× 199 0.7× 13 714
Nicole H. Moraco United States 12 1.1k 1.2× 237 0.7× 190 0.6× 227 0.8× 423 1.6× 14 1.3k
Dominic Cellier France 12 720 0.8× 245 0.7× 188 0.6× 128 0.5× 151 0.6× 25 1.0k
D L Longo United States 6 390 0.4× 140 0.4× 306 1.0× 58 0.2× 69 0.3× 6 743
A. Lurkin France 12 736 0.8× 238 0.7× 239 0.8× 129 0.5× 154 0.6× 16 1.0k
M. L. Samuels United States 17 379 0.4× 556 1.6× 69 0.2× 152 0.5× 68 0.3× 34 939
V. Benk Canada 13 775 0.9× 336 1.0× 117 0.4× 353 1.3× 138 0.5× 22 1.1k
Giacomo Giulio Baldi Italy 20 843 1.0× 254 0.7× 251 0.8× 526 1.9× 135 0.5× 71 1.6k
Maristella Saponara Italy 20 640 0.7× 350 1.0× 94 0.3× 82 0.3× 111 0.4× 70 1.2k
B. Bui France 11 487 0.6× 176 0.5× 154 0.5× 148 0.5× 121 0.4× 22 637

Countries citing papers authored by E. Gehan

Since Specialization
Citations

This map shows the geographic impact of E. Gehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Gehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Gehan more than expected).

Fields of papers citing papers by E. Gehan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Gehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Gehan. The network helps show where E. Gehan may publish in the future.

Co-authorship network of co-authors of E. Gehan

This figure shows the co-authorship network connecting the top 25 collaborators of E. Gehan. A scholar is included among the top collaborators of E. Gehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Gehan. E. Gehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Liu, Aiyi, Weichung Joe Shih, & E. Gehan. (2002). Sample size and power determination for clustered repeated measurements. Statistics in Medicine. 21(12). 1787–1801. 31 indexed citations
2.
Gehan, E.. (2001). The role of the biostatistician in cancer research. Biomedicine & Pharmacotherapy. 55(9-10). 502–509. 4 indexed citations
3.
Arndt, Carola, Mariella C. Tefft, E. Gehan, et al.. (1997). A Feasibility, Toxicity, and Early Response Study of Etoposide, Ifosfamide, and Vincristine for the Treatment of Children with Rhabdomyosarcoma: A Report from the Intergroup Rhabdomyosarcoma Study (IRS) IV Pilot Study. ˜The œAmerican journal of pediatric hematology/oncology. 19(2). 124–129. 43 indexed citations
4.
Ruymann, Frederick B., Teresa J. Vietti, E. Gehan, et al.. (1995). Cyclophosphamide Dose Escalation in Combination with Vincristine and Actinomycin-D (VAC) in Gross Residual Sarcoma. Journal of Pediatric Hematology/Oncology. 17(4). 331–337. 34 indexed citations
5.
Evans, Roger G., M E Nesbit, E. Gehan, et al.. (1991). Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study.. Journal of Clinical Oncology. 9(7). 1173–1180. 122 indexed citations
6.
Gehan, E., M. P. Sullivan, Lillian M. Fuller, et al.. (1990). The intergroup Hodgkin's disease in children. A study of stages I and II. Cancer. 65(6). 1429–1437. 33 indexed citations
7.
Cangır, Ayten, Teresa J. Vietti, E. Gehan, et al.. (1990). Ewing's sarcoma metastatic at diagnosis results and comparisons of two intergroup Ewing's sarcoma studies. Cancer. 66(5). 887–893. 153 indexed citations
8.
Nesbit, M., E. Gehan, E. Omer Burgert, et al.. (1990). Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.. Journal of Clinical Oncology. 8(10). 1664–1674. 434 indexed citations breakdown →
9.
Raney, R. Beverly, Melvin Tefft, Harold M. Maurer, et al.. (1988). Disease patterns and survival rate in children with metastatic soft-tissue sarcoma: A report from the intergroup rhabdomyosarcoma study (IRS)-I. Cancer. 62(7). 1257–1266. 61 indexed citations
10.
Gehan, E., et al.. (1986). Phase II trial of bisantrene in patients with advanced sarcoma: a Southwest Oncology Group Study.. PubMed. 70(5). 685–6. 6 indexed citations
11.
Tefft, Mariella C., et al.. (1984). Radiotherapy (RT) for rhabdomyosarcoma (RMS) in children: A report from the intergroup rhabdomyosarcoma study #2 (IRS-2) (Funding # CA 24507). International Journal of Radiation Oncology*Biology*Physics. 10. 86–86. 5 indexed citations
12.
Barlogie, Bart, et al.. (1983). Marrow cytometry and prognosis in myeloma.. Journal of Clinical Investigation. 72(3). 853–861. 41 indexed citations
13.
Fisher, Richard I., Chris Fryer, E. Gehan, et al.. (1982). Intergroup Hodgkin's disease in children study of stages I and II: a preliminary report.. PubMed. 66(4). 937–47. 17 indexed citations
14.
Tefft, Mariella C., Robert D. Lindberg, & E. Gehan. (1981). Radiation therapy combined with systemic chemotherapy of rhabdomyosarcoma in children: local control in patients enrolled in the Intergroup Rhabdomyosarcoma Study.. PubMed. 75–81. 37 indexed citations
15.
Pérez, Cirilo, Melvin Tefft, Mark Nesbit, et al.. (1981). Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study.. PubMed. 263–71. 20 indexed citations
16.
Pérez, Cirilo, Melvin Tefft, Mark Nesbit, et al.. (1979). Radiation therapy in the multimodality management of Ewing's Sarcoma of bone A report of the intergroup EWING'S SARCOMA study group. International Journal of Radiation Oncology*Biology*Physics. 5. 99–99. 1 indexed citations
17.
Lh, Baker, et al.. (1976). Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.. PubMed. 60(6). 733–7. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026